BioSpace News Archive

Indo-Irish biotech startup CyGenica secures funding from SOSV to accelerate cancer and rare genetic disease therapy

CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV.

June 10, 2021
·
2 min read
Pharm Country

AUM LifeTech, Inc. to Present Preclinical Developments on Lung Cancer, Parkinson’s Disease, and HIV at BIO Digital 2021

AUM LifeTech, Inc., a preclinical stage biotechnology company, announced today that it has been selected by the National Institutes of Health (NIH) to present an update on their drug development pipeline at 2021 BIO Digital, the premier biotech event

June 10, 2021
·
3 min read
FDA

Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform

Medtronic plc (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for Vanta™, a high performance recharge-free implantable neurostimulator device life that can be optimized up to 11 years.

June 10, 2021
·
4 min read
Drug Development

Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease

Anji Pharma (“Anji”) has initiated a pivotal trial of ANJ900 (delayed-release metformin) in patients with Type 2 diabetes (T2D), including those with varying stages of renal disease.

June 10, 2021
·
3 min read
Axiom Presents “Benefits and Advantages of a Unified Platform Approach to Global Studies” at BIO Digital 2021

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at BIO Digital 2021, the world’s largest virtual biotech partnering and education event.

June 10, 2021
·
2 min read
BioMidwest

Walgreens Continues to Boost COVID-19 Vaccination Access Across the Country

As part of the Biden Administration’s National Month of Action, Walgreens will extend pharmacy hours of operation each Friday in June to provide those who may have limited time the additional flexibility needed to get a COVID-19 vaccine.

June 10, 2021
·
3 min read
Drug Development

ImmunityBio Announces HIV Clinical Pipeline with Opening of a Phase 1 ‘HIV Cure Study’ in Patients Off Therapy and a Phase 2 Study in Acutely Infected Patients

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced its HIV clinical pipeline with an HIV cure study using Anktiva™ (N-803), which is now enrolling participants in the U.S

June 10, 2021
·
10 min read
Business

SAB Biotherapeutics Appoints Carlos Carrillo, PhD, as Senior Vice President, Regulatory Affairs

SAB Biotherapeutics (SAB), today announced the appointment of Carlos Carrillo, PhD, as senior vice president, regulatory affairs.

June 10, 2021
·
3 min read
Pharm Country

NCCN Cancer Experts Answer Questions about COVID-19 Vaccines

The National Comprehensive Cancer Network® announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers.

June 10, 2021
·
4 min read
Business

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

Dr. Roberts brings three decades of expertise to further expand ElevateBio’s immunotherapy leadership across its protein, viral, and cell engineering technology platforms

June 10, 2021
·
5 min read